Article

Alcon debuts WaveLight EX500 excimer laser

Alcon Laboratories introduced its latest innovation in LASIK surgery technology, the WaveLight EX500 excimer laser, during the 2012 meeting of the American Society of Cataract and Refractive Surgery.

Chicago-Alcon Laboratories introduced its latest innovation in LASIK surgery technology, the WaveLight EX500 excimer laser, during the 2012 meeting of the American Society of Cataract and Refractive Surgery.

The excimer laser delivers an upgradable platform, with an advanced multi-dimensional 1,050-Hz tracker synchronized at 500 Hz, non-contact dynamic pachymetry, and a communication-ready small/sleek footprint. It also delivers a 500-Hz pulse frequency laser capable of a 1.4 sec/D ablation, making this excimer laser the fastest in the United States, the company said in a prepared statement.

“The added benefits and features of the WaveLight EX500 excimer laser are numerous and further demonstrate our commitment to bringing surgeons the most advanced technologies to meet a wide range of patient needs accurately and efficiently,” said Jim Thomas, vice president and general manager, Alcon U.S. Surgical business.

The laser was approved for sale in the United States by the FDA in the fourth quarter of 2011. This is the first refractive surgery innovation that Alcon has unveiled since its merger with Novartis in April 2011.

For more articles in this issue of Ophthalmology Times Conference Briefclick here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.